文献速递艾滋病与性传播感染

人类免疫缺陷病毒(HIV)感染者的维生素C尿液丢失与缺乏:HIV感染女性维生素C肾性漏出的横断面研究

Vitamin C Urinary Loss and Deficiency in Human Immunodeficiency Virus (HIV): Cross-sectional Study of Vitamin C Renal Leak in Women With HIV.
PubMed 文献 · Clin Infect Dis · 2023-01-01

在美国国立卫生研究院和乔治城大学开展的门诊横断面研究纳入96名女性(40名HIV感染者、56名未感染者),发现HIV感染者维生素C肾性漏出患病率显著更高(73% vs 14%;OR 16;P<.001),平均血浆维生素C更低(14µM vs 50µM;P<.001),维生素C缺乏患病率更高(43% vs 7%;OR 10;P<.001),调整混杂因素后不变。

要点

  • HIV感染女性维生素C肾性漏出患病率为73%,显著高于未感染女性的14%(OR 16;P<.001)。
  • HIV感染女性平均血浆维生素C为14µM,低于未感染女性的50µM(P<.001)。
  • HIV感染女性维生素C缺乏患病率为43%,高于未感染女性的7%(OR 10;P<.001)。

核心结论

  • HIV感染者中维生素C肾性漏出高患病率与维生素C缺乏、抗逆转录病毒治疗使用及种族/民族差异相关。

研究设计与样本

  • 在美国国立卫生研究院和乔治城大学开展的门诊横断面研究,纳入96名女性,其中40名HIV感染者(PWH)、56名未感染HIV者(PWOH)。
  • 肾性漏出定义为空腹血浆浓度<43.2µM时尿液维生素C排泄异常,该阈值低于健康女性维生素C肾阈值2个标准差。
  • 过夜空腹后次日晨采集配对的尿液和血浆样本以确定肾性漏出患病率这一主要结局。
  • 维生素C采用高效液相色谱-库仑电化学检测法测定。

主要发现

  • HIV感染者肾性漏出患病率为73%,未感染者(PWOH)为14%(OR 16;P<.001)。
  • HIV感染者平均血浆维生素C浓度为14µM,未感染者为50µM(P<.001)。
  • HIV感染者维生素C缺乏患病率为43%,未感染者为7%(OR 10;P<.001)。
  • 上述结果经混杂因素调整后不变。
  • 肾性漏出的显著预测因素包括抗逆转录病毒治疗(ART)、黑人种族、年龄较大和代谢合并症,而非病毒载量或CD4计数。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reduced plasma vitamin C (vitC) concentrations in human immunodeficiency virus (HIV) may result from abnormal urinary excretion: a renal leak. VitC renal leak indicates underlying nutritional dysregulation independent of diet. We hypothesized that increased renal leak prevalence in HIV would be associated with deficient vitC concentrations. METHODS: We conducted an outpatient cross-sectional study of 96 women (40 HIV [PWH] and 56 without HIV [PWOH]) at the National Institutes of Health and Georgetown University. Renal leak was defined as abnormal urinary vitC excretion at fasting plasma concentrations <43.2µM, 2 SDs below vitC renal threshold in healthy women. To determine the primary outcome of renal leak prevalence, matched urine and plasma samples were collected the morning after overnight fast. Secondary outcomes assessed group differences in mean plasma vitC concentrations and prevalence of vitC deficiency. Exploratory outcomes assessed clinical parameters associated with renal leak. VitC was measured by high-performance liquid chromatography with coulometric electrochemical detection. RESULTS: PWH had significantly higher renal leak prevalence (73%vs14%; OR (odds ratio):16; P<.001), lower mean plasma vitC concentrations (14µMvs50µM; P<.001), and higher prevalence of vitC deficiency (43%vs7%; OR:10; P<.001) compared with PWOH, unchanged by adjustments for confounding factors. Significant predictors of renal leak included antiretroviral therapy (ART), Black race, older age, and metabolic comorbidities but not viral load or CD4 count. When compared with other chronic disease cohorts, PWH had the highest prevalence of renal leak and vitC deficiency (P<.001). CONCLUSIONS: High prevalence of vitC renal leak in HIV was associated with vitC deficiency, ART use, and race/ethnicity differences.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ebenuwa I, Violet PC, Michel K, et al. Vitamin C Urinary Loss and Deficiency in Human Immunodeficiency Virus (HIV): Cross-sectional Study of Vitamin C Renal Leak in Women With HIV. Clin Infect Dis. 2023. PMID: 37264998. doi:10.1093/cid/ciad333

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。